We are pleased to announce that new pseudovirus in vitro neutralization data show continued neutralizing activity of pemivibart and pipeline candidate VYD2311 against dominant SARS-CoV-2 variants KP.3.1.1 and LB.1, and others tested. Learn more in our latest press release: https://lnkd.in/e-rm-JXY #covid19 #covid
Invivyd
Biotechnology Research
Waltham, Massachusetts 10,603 followers
Devoted to delivering protection from serious viral infectious diseases.
About us
Invivyd, Inc. (Nasdaq: IVVD) is a commercial-stage company is a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases. Leveraging state-of-the-art viral surveillance, predictive modeling, and advanced antibody engineering techniques, we are taking a platform-based approach to the continuous discovery and optimization of monoclonal antibody candidates designed to protect the vulnerable from serious viral threats. In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for its first mAb in a planned series of innovative antibody candidates. Visit https://invivyd.com/ to learn more.
- Website
-
http://www.invivyd.com
External link for Invivyd
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Waltham, Massachusetts
- Type
- Public Company
- Founded
- 2020
Locations
-
Primary
1601 Trapelo Rd
Suite 178
Waltham, Massachusetts 02451, US
Employees at Invivyd
Updates
-
Happy Invivyd-versary to Hilda Gonzalez, Alexander V., and Braedon Williams! Thank you for all you do to make Invivyd a great place to work. We are lucky to have each of you as part of the team! #weareinvivyd #covid19
-
We are pleased to highlight Jennifer Jacobson, our HR Coordinator. She was recently recognized by a colleague for her embodiment of our core value proactive – she regularly goes above and beyond to help, and always does it with a smile on her face. A big thank you to Jen for showcasing the Vydian spirit! #weareinvivyd
-
Invivyd is devoted to delivering protection from serious viral infectious diseases. If you’re passionate about protecting vulnerable people from the devastating consequences of circulating viral threats then check out our open positions! Link in the comments. #hiringnow #regulatory #marketing #covid19 #cnenetwork
-
Meet Daniel Chupp, Ph.D., Pre-Clinical and Discovery Scientist. He shares why he chose Invivyd and why he stays. #weareinvivyd #covid19
-
Last week, we held our latest session of Invivyd Illuminated. This half-day program is an opportunity to welcome our newest Vydians to the team and includes multiple sessions to provide attendees a better understanding of the various functions within Invivyd. Thank you to Margarita Malhotra, CIPP, CCEP, Jill Langer, MSN, FNP-BC, Dayna Mcadams, BSN, Shawn Gibbs, JD, Colin Powers, Shannon Holmes, Ph.D., RAC, Jillian Whidby, PhD, Erica LoRe, Rosemary Townshend and Aldwin Aldana, MS, RQAP-GLP, RQAP-GCP for your participation, and to Danielle Looney and Jennifer Park for leading an engaging session! #weareinvivyd #covid19
-
Last week, we enjoyed bringing together many cross-functional team members for a strategic summit to collaborate, build relationships, discuss our vision, and reflect on our priorities. The absolute highlight was hearing from an immunocompromised patient who reminded us of the critical importance of our work because while COVID-19 safety mitigations are being stripped away, she and many other vulnerable people like her are still living in a world that feels small where human connection is scarce, and worry – just like COVID-19 – is here to stay. #covid19
-
Happy Invivyd-versary to Mark Jaeger, Feng Gao, and Scott Vautin! Thank you for your hard work, determination, and spirit. We are lucky to have each of you as part of the team! #weareinvivyd